Q-omics provides the consensus-scored OR6C66P profile across patient tissues and cancer cell-line models. OR6C66P expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, OR6C66P RNA expression shows 5,100 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUSC, and STAD as cancer lineages where OR6C66P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for OR6C66P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes OR6C66P survival associations across molecular data types. OR6C66P RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

OR6C66P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	11	LUSC (99)	view →

This table ranks reproducible OR6C66P RNA expression–survival associations across cancer types. High OR6C66P expression shows unfavorable associations in LUSC, KICH, THCA, THYM, STAD and ESCA. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUSC as the clearest survival context for OR6C66P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.270	0.666	<.001	99	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
THCA	DFS	Tertile	II,III,IV	0.468	0.911	<.001	45	view →
THYM	OS	Tertile	II,III,IV	0.186	0.851	<.001	36	view →
STAD	OS	Tertile	All	0.328	0.569	.012	30	view →
ESCA	OS	Tertile	All	0.381	0.583	.017	24	view →

Pink = unfavorable, green = favorable. all 11 lineages →

OR6C66P-LUSC (DFS)

Kaplan–Meier survival curve for OR6C66P RNA expression in LUSC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with OR6C66P in patient tissues and cancer cell lines. In patient samples, OR6C66P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,100	STAD (4709)	view →
RNA	2,183	DLBC (886)	view →